» Articles » PMID: 37445452

Intimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients

Abstract

Background: Arteriovenous fistula dysfunction is a widely disputed subject in the scientific literature on end-stage kidney disease (ESKD). The main cause of mortality and morbidity in these patients is the non-maturation or dysfunction of the arteriovenous fistula. Despite the many complications, the native arteriovenous fistula remains the gold standard in the treatment of these patients requiring renal replacement. This study aims to discuss the predictive role of some systemic inflammatory biomarkers (NLR, PLR, SII, IL-6), intimal hyperplasia, and neoangiogenesis (characterized by intimal-media CD31-positive relative surface) in arteriovenous fistula maturation failure.

Methods: The present study was designed as an observational, analytical, and prospective study which included patients diagnosed with ESKD with indications of radio-cephalic arteriovenous fistula (RCAVF). Demographic data, comorbidities, preoperative laboratory data and histological/digital morphometry analysis results were processed. The patients included were divided into two groups based on their AVF maturation status at 8 weeks: "Maturation" (Group 1) and "Failed Maturation" (Group 2).

Results: There was no difference in the demographic data. In terms of comorbidities, the second group had a greater incidence of heart failure ( = 0.03), diabetes ( = 0.04), peripheral artery disease ( = 0.002), and obesity ( = 0.01). Additionally, regarding the laboratory findings, these patients had higher levels of serum uric acid ( = 0.0005), phosphates ( < 0.0001), and creatinine ( = 0.02), as well as lower levels of total calcium ( = 0.0002), monocytes ( = 0.008), and lymphocytes ( < 0.0001). Moreover, all inflammatory markers ( = 0.001; < 0.0001; = 0.006, and = 0.03) and Ca-P product ( < 0.0001) had higher baseline values in Group 2. Upon immunohistochemical analysis, regarding the density of neoformed vessels, there was a higher incidence of CD31-positive surfaces ( = 0.006) and CD31-positive relative surfaces ( = 0.001); the NLR (r = 0.323; = 0.03), PLR (r = 0.381; = 0.04), SII (r = 0.376; = 0.03), and IL-6 (r = 0.611; < 0.001) are all significantly correlated with vascular density, as evidenced by CD31.

Conclusions: Heart failure, peripheral artery disease, obesity, and diabetes, as well as the systemic inflammatory markers (NLR, PLR, SII, IL-6), intimal hyperplasia, and CD31-positive relative surfaces are predictors of arteriovenous fistula maturation failures.

Citing Articles

Elevated Interleukin-6 Is Associated with an Increased Risk of Long-Term Arteriovenous Fistula Failure for Dialysis.

Ciucanu C, Muresan A, Florea E, Reka B, Muresan A, Szanto L J Clin Med. 2025; 14(2).

PMID: 39860495 PMC: 11765527. DOI: 10.3390/jcm14020488.


Elevated Leukocyte Glucose Index Is Associated with Long-Term Arteriovenous Fistula Failure in Dialysis Patients.

Muresan A, Florea E, Arbanasi E, Bartus R, Arbanasi E, Ion A J Clin Med. 2024; 13(7).

PMID: 38610802 PMC: 11012331. DOI: 10.3390/jcm13072037.


Differential expression of serum TM, PAF, and CD62P in patients with autologous arteriovenous fistula and the correlation with vascular access function.

Jiang Y, Liu Z, Liu L, Xiong Z, Chen Y, Zhang S Immun Inflamm Dis. 2024; 12(3):e1227.

PMID: 38533915 PMC: 10966918. DOI: 10.1002/iid3.1227.


Therapeutic strategies based on non-ionizing radiation to prevent venous neointimal hyperplasia: the relevance for stenosed arteriovenous fistula, and the role of vascular compliance.

Russu E, Arbanasi E, Chirila T, Muresan A Front Cardiovasc Med. 2024; 11:1356671.

PMID: 38374996 PMC: 10875031. DOI: 10.3389/fcvm.2024.1356671.

References
1.
Tuysuz M, Dedemoglu M . Calcium phosphate product level as a predictor for arteriovenous fistula re-operations in patients with chronic renal failure. Vascular. 2018; 27(3):284-290. DOI: 10.1177/1708538118814611. View

2.
Tabbara M, Duque J, Martinez L, Escobar L, Wu W, Pan Y . Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes. Am J Kidney Dis. 2016; 68(3):455-64. PMC: 5002252. DOI: 10.1053/j.ajkd.2016.02.044. View

3.
Kaller R, Muresan A, Arbanasi E, Arbanasi E, Kovacs I, Horvath E . Uncommon Surgical Management by AVF between the Great Saphenous Vein and Anterior Tibial Artery for Old Radiocephalic AVF Failure. Life (Basel). 2022; 12(4). PMC: 9025436. DOI: 10.3390/life12040529. View

4.
Niculescu R, Russu E, Arbanasi E, Kaller R, Arbanasi E, Melinte R . Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy. Int J Environ Res Public Health. 2022; 19(21). PMC: 9654888. DOI: 10.3390/ijerph192113934. View

5.
Huijbregts H, Bots M, Wittens C, Schrama Y, Moll F, Blankestijn P . Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol. 2008; 3(3):714-9. PMC: 2386712. DOI: 10.2215/CJN.02950707. View